Skip to content

Psychedelic-Assisted Therapy: A Promising Trend for Mental Health

A new trend that is showing promise for some mental health issues is the use of psychedelics in therapeutic settings. Psychoactive drugs like psilocybin, LSD, or MDMA are given as part of psychedelic therapy combined with a therapist’s psychological support. Psychedelic-assisted therapy is being investigated as a potential treatment for disorders such as depression, anxiety, PTSD, addiction, and end-of-life distress, however research on this topic is still in its early phases.

Indigenous cultures have been using psychedelics for medicinal purposes for thousands of years. These cultures used plant medicines in their healing and coming-of-age ceremonies. Psychedelics were the subject of scientific investigation in modern psychiatry starting in the 1950s and continuing until the 1970s when they were outlawed.

The last 20 years have seen a rebirth of psychedelic medical research after decades of hibernation. Extensive research conducted at prestigious universities such as Imperial College London and Johns Hopkins University has shown that, under carefully monitored conditions, psychedelics can be very therapeutically effective.

So how are psychedelic sessions used nowadays for therapeutic purposes? Prior to supervised dosage sessions, patients are extensively screened and prepared for. During psychedelic experiences, participants are assessed for risk factors and mental health support. The sessions are conducted in a welcoming, visually appealing setting with certified therapists in attendance.

After receiving a dosage of MDMA, LSD, or psilocybin, patients undergo 8 to 12 hours of supported therapeutic processing. Therapists assist patients in processing new information and feelings while also offering empathy and assistance. After the effects of the medication wear off, follow-up integrative sessions are essential for consolidating learning and applying lessons to everyday life.

According to participants, psychedelic sessions frequently lead to fresh insights about memories, relationships, and personal concerns. According to reports of altered consciousness, psychedelics modify neuronal activity and connection in ways that are corroborated by brain imaging.

After assimilating the experience, symptoms of disorders like depression, anxiety, or PTSD can be significantly and sustainably reduced for some people after just one or two supervised psychedelic sessions. The ways in which this method enhances other therapeutic techniques are still being investigated.

Approximately 80% of patients with terminal illnesses who received psychedelic therapy reported significant reductions in anxiety and depression in studies for end-of-life distress. Patients’ last few months of life were enhanced as a result. Psychedelics are seen as a therapeutic catalyst rather than a panacea.

Participants can momentarily see their life through a fresh, prejudice-free lens thanks to the psychedelic experience. Reports of increased empathy, spirituality, and a sense of oneness are not uncommon. Psychedelics provide a doorway into this enlarged level of awareness, which can help patients have breakthroughs in their minds, emotions, or spirituality that provide the groundwork for their recovery.

Psychedelics are thought to reduce harmful urges and enable people to look more critically at their behaviour when used in addiction treatment. Following a psychedelic encounter, trial participants report feeling more motivated than ever to maintain sobriety. Up to 80% of participants in trials using psychedelics to stop smoking achieved abstinence over a six-month period, while conventional treatments only achieved 35% of this level of success.

Research on psychedelic therapy is still in its early stages, but it seems promising. Before being widely accepted, there are issues with patient selection criteria, predictive biomarkers, and integration techniques that need to be resolved. Critics contend that additional data is required to determine the therapy’s long-term efficacy and safety. To properly manage risks, qualified individuals and appropriate methods are needed.

Over the next ten years, experts anticipate that controlled psychedelic therapy will move from research to a recognised mental health treatment. To further prove efficacy, more double-blind studies with bigger sample numbers are needed. As research progresses, psychedelic therapy might become a practical choice for those seeking a different approach to treatment when they are not responding to conventional methods. Legally and morally carried out, a psychedelic session has the potential to be extremely effective in treating mental health issues and helping patients reintegrate into society.